X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs SUVEN LIFE - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD SUVEN LIFE LUPIN LTD/
SUVEN LIFE
 
P/E (TTM) x 28.3 19.3 146.6% View Chart
P/BV x 3.0 4.2 70.2% View Chart
Dividend Yield % 0.6 0.5 103.7%  

Financials

 LUPIN LTD   SUVEN LIFE
EQUITY SHARE DATA
    LUPIN LTD
Mar-18
SUVEN LIFE
Mar-18
LUPIN LTD/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs1,465251 584.1%   
Low Rs727155 469.1%   
Sales per share (Unadj.) Rs349.649.1 711.6%  
Earnings per share (Unadj.) Rs5.69.7 57.2%  
Cash flow per share (Unadj.) Rs29.611.4 259.6%  
Dividends per share (Unadj.) Rs5.001.50 333.3%  
Dividend yield (eoy) %0.50.7 61.7%  
Book value per share (Unadj.) Rs300.360.3 498.1%  
Shares outstanding (eoy) m452.08127.28 355.2%   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x3.14.1 75.9%   
Avg P/E ratio x197.220.9 944.5%  
P/CF ratio (eoy) x37.117.8 208.1%  
Price / Book Value ratio x3.63.4 108.4%  
Dividend payout %90.015.4 582.8%   
Avg Mkt Cap Rs m495,50225,825 1,918.7%   
No. of employees `00017.01.1 1,589.7%   
Total wages/salary Rs m28,647613 4,675.6%   
Avg. sales/employee Rs Th9,273.65,832.6 159.0%   
Avg. wages/employee Rs Th1,681.0571.5 294.1%   
Avg. net profit/employee Rs Th147.41,153.8 12.8%   
INCOME DATA
Net Sales Rs m158,0426,253 2,527.6%  
Other income Rs m1,504233 646.1%   
Total revenues Rs m159,5456,485 2,460.1%   
Gross profit Rs m31,4751,982 1,588.2%  
Depreciation Rs m10,859213 5,095.6%   
Interest Rs m2,04446 4,413.6%   
Profit before tax Rs m20,0761,955 1,026.9%   
Minority Interest Rs m-710-   
Prior Period Items Rs m350-   
Extraordinary Inc (Exp) Rs m-14,6440-   
Tax Rs m2,885718 401.6%   
Profit after tax Rs m2,5131,237 203.1%  
Gross profit margin %19.931.7 62.8%  
Effective tax rate %14.436.7 39.1%   
Net profit margin %1.619.8 8.0%  
BALANCE SHEET DATA
Current assets Rs m122,0955,622 2,171.6%   
Current liabilities Rs m50,9561,168 4,364.1%   
Net working cap to sales %45.071.2 63.2%  
Current ratio x2.44.8 49.8%  
Inventory Days Days8581 103.9%  
Debtors Days Days12036 333.8%  
Net fixed assets Rs m129,8763,325 3,906.5%   
Share capital Rs m904127 710.3%   
"Free" reserves Rs m134,8667,547 1,787.1%   
Net worth Rs m135,7717,674 1,769.2%   
Long term debt Rs m64,24514 462,194.2%   
Total assets Rs m263,0549,135 2,879.5%  
Interest coverage x10.843.2 25.0%   
Debt to equity ratio x0.50 26,124.4%  
Sales to assets ratio x0.60.7 87.8%   
Return on assets %1.714.0 12.3%  
Return on equity %1.916.1 11.5%  
Return on capital %3.726.0 14.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m53,1415,066 1,049.0%   
Fx outflow Rs m19,3352,001 966.2%   
Net fx Rs m33,8073,065 1,103.0%   
CASH FLOW
From Operations Rs m17,512699 2,503.8%  
From Investments Rs m-14,073-6 230,700.0%  
From Financial Activity Rs m-14,921-577 2,585.9%  
Net Cashflow Rs m-11,482116 -9,872.5%  

Share Holding

Indian Promoters % 46.6 63.4 73.5%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 0.0 -  
FIIs % 31.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 36.5 27.7%  
Shareholders   98,259 37,287 263.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   GSK PHARMA  NATCO PHARMA  BIOCON LTD  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare LUPIN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Marginally Lower; FMCG & IT Stocks Witness Losses(Closing)

After opening the day on a positive note today, Indian share markets witnessed losses thereafter and ended their trading session marginally lower.

Related Views on News

SUVEN LIFE Surges by 5%; BSE HEALTHCARE Index Up 1.3% (Market Updates)

Sep 26, 2018 | Updated on Sep 26, 2018

SUVEN LIFE share price has surged by 5% and its current market price is Rs 289. The BSE HEALTHCARE is up by 1.3%. The top gainers in the BSE HEALTHCARE Index is SUVEN LIFE (up 5.3%). The top losers are PIRAMAL ENTERPRISES (down 0.2%) and FORTIS HEALTHCARE (down 0.5%).

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Oh Yes! This is the Best Trading Opportunity in Two Decades(Profit Hunter)

Sep 21, 2018

Getting ready to buy stocks once this correction is over? This private sector bank should be on a profit hunter's radar.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

How To Identify Sachin Tendulkars And Rahul Dravids Of Tomorrow For Your Mutual Fund Portfolio(Outside View)

Sep 19, 2018

PersonalFN explains how to pick 'undiscovered' or lesser-known mutual funds that are capable of generating big gains for you.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Sep 26, 2018 03:37 PM

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD 8-QTR ANALYSIS

COMPARE LUPIN LTD WITH

MARKET STATS